These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16095755)

  • 21. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma.
    Prickett TC; Yandle TG; Nicholls MG; Espiner EA; Richards AM
    Biochem Biophys Res Commun; 2001 Aug; 286(3):513-7. PubMed ID: 11511088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology.
    Gøtze JP; Kastrup J
    Scand J Clin Lab Invest Suppl; 2001; 234():47-51. PubMed ID: 11713980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
    Nishikimi T; Kuwahara K; Nakao K
    J Cardiol; 2011 Mar; 57(2):131-40. PubMed ID: 21296556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptide and adrenomedullin levels in chronic renal failure and effects of peritoneal dialysis.
    Obineche EN; Pathan JY; Fisher S; Prickett TC; Yandle TG; Frampton CM; Cameron VA; Nicholls MG
    Kidney Int; 2006 Jan; 69(1):152-6. PubMed ID: 16374436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides in relation to the cardiac innervation and conduction system.
    Hansson M
    Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans.
    Clerico A; Iervasi G; Mariani G
    Horm Metab Res; 1999 Sep; 31(9):487-98. PubMed ID: 10569249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do natriuretic peptides modify arterial baroreflexes in sheep?
    Thomas CJ; Woods RL
    Exp Physiol; 2004 Nov; 89(6):709-15. PubMed ID: 15364878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of homologous natriuretic peptides on growth hormone and prolactin release in the tilapia, Oreochromis mossambicus.
    Fox BK; Naka T; Inoue K; Takei Y; Hirano T; Grau EG
    Gen Comp Endocrinol; 2007 Jan; 150(2):270-7. PubMed ID: 17107675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
    Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
    Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
    Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.